Dermata Therapeutics, Inc. (DRMA): Price and Financial Metrics
DRMA Price/Volume Stats
| Current price | $1.16 | 52-week high | $13.35 |
| Prev. close | $1.08 | 52-week low | $1.05 |
| Day low | $1.07 | Volume | 548,400 |
| Day high | $1.45 | Avg. volume | 780,169 |
| 50-day MA | $1.45 | Dividend yield | N/A |
| 200-day MA | $3.41 | Market Cap | 2.37M |
DRMA Stock Price Chart Interactive Chart >
Dermata Therapeutics, Inc. (DRMA) Company Bio
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. Its lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. The company was founded in 2014 and is headquartered in San Diego, California.
DRMA Price Returns
| 1-mo | -26.11% |
| 3-mo | -35.20% |
| 6-mo | -65.68% |
| 1-year | -89.12% |
| 3-year | -99.80% |
| 5-year | N/A |
| YTD | -87.32% |
| 2023 | -90.68% |
| 2022 | -76.49% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...